- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03294187
Encouragement-induced Movement Therapy in Daily Life (ISEAR)
Encouragement-induced Movement Therapy in Daily Life - a Randomized Controlled, Assessor-blinded Multi-center Trial in Stroke Patients With a Unilateral Hemiparesis, Using a Wrist-worn Tracking and Feedback Device
Stroke places a major burden on health care and society. It often leads to a hemiparesis. Intensive stroke rehabilitation speeds up recovery. In daily practice, the financial and/or human resources to provide this intensive rehabilitation are often lacking. Applying modern-day tracking and feedback technology to encourage a self-administered, context specific training is expected to offer significant potential to increase intensity of practice. Up until now, there has been no randomized trial examining the effect of such an intervention on daily arm usage.
The primary objective of this study is to determine the effect of wearing an activity tracking and multimodal feedback device for six weeks on self-reported daily life use of the paretic arm after stroke, when compared to control group stroke subjects wearing a hardware-wise identical sham device providing no feedback. The secondary aim is to examine compliance to use the device and the quantitative, qualitative and functional improvement of the paretic arm. It is hypothesized that participants in the experimental group show a higher change in self-reported daily life use of the paretic arm when compared to the control group both post intervention and at 6-week follow-up.
ISEAR is a multicenter, assessor-blinded randomized controlled trial of 62 subjects beyond the first 3 months poststroke.
Studieoversikt
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Vitznau, Sveits
- Cereneo, Center For Neurology and Rehabilitation
-
Wald, Sveits
- Zürcher RehaZentrum Wald
-
Zürich, Sveits
- University Hospital Zurich
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Above 18 years of age with unilateral stroke and residual hemiparesis leading to a decrease of arm function after completion of all inpatient rehabilitation (at least 90 days post stroke)
- Ability to lift arm against gravity (>30 degrees flexion or abduction)
- Ability to don/doff the devices on both wrists independently or with assistance of a caregiver
- Ability to give informed consent as documented by signature
Exclusion Criteria:
- Major untreated depression
- Severe cognitive impairment
- Suffering from comprehensive aphasia
- Severely impaired sensation (unable to feel a soft touch on the dorsal side of their paretic wrist with closed eyes)
- Other major comorbidities (e.g., cardiopulmonary disease, renal failure, hepatic dysfunction, orthopedic disorders, etc.)
- Expected hospitalization during study period
- Known intolerance to device material
- Known or suspected non-compliance, drug or alcohol abuse
- The investigator, his/her family members, employees, and other dependent persons
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Monitoring and Feedback
Subjects will use two wrist-worn wearables over a period of 6 weeks.
Patients will receive multimodal (vibrotactile and visual) feedback.
|
See arm/group description.
|
Placebo komparator: Monitoring
Study subjects will use identical devices over a period of 6 weeks.
Patients will *not* receive multimodal feedback.
|
See arm/group description.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Motor Activity Log - 14, Amount of Use sub scale
Tidsramme: Post-intervention (6 weeks)
|
Self-reported amount of upper limb use in daily life
|
Post-intervention (6 weeks)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Fugl-Meyer Assessment, Upper Extremity sub scale
Tidsramme: Post-intervention (6 weeks)
|
Upper limb motor function
|
Post-intervention (6 weeks)
|
Fugl-Meyer Assessment, Upper Extremity sub scale
Tidsramme: Follow-up (12 weeks)
|
Upper limb motor function
|
Follow-up (12 weeks)
|
Action Research Arm Test
Tidsramme: Post-intervention (6 weeks)
|
Upper limb capacity
|
Post-intervention (6 weeks)
|
Action Research Arm Test
Tidsramme: Follow-up (12 weeks)
|
Upper limb capacity
|
Follow-up (12 weeks)
|
Modified Rankin Scale
Tidsramme: Post-intervention (6 weeks)
|
Global Disability
|
Post-intervention (6 weeks)
|
Modified Rankin Scale
Tidsramme: Follow-up (12 weeks)
|
Global Disability
|
Follow-up (12 weeks)
|
EuroQol five dimensions five levels questionnaire
Tidsramme: Post-intervention (6 weeks)
|
Quality of Life
|
Post-intervention (6 weeks)
|
EuroQol five dimensions five levels questionnaire
Tidsramme: Follow-up (12 weeks)
|
Quality of Life
|
Follow-up (12 weeks)
|
Motor Activity Log - 14, Quality of Movement sub scale
Tidsramme: Post-intervention (6 weeks)
|
Self-reported quality of upper limb use in daily life
|
Post-intervention (6 weeks)
|
Motor Activity Log - 14, Quality of Movement sub scale
Tidsramme: Follow-up (12 weeks)
|
Self-reported quality of upper limb use in daily life
|
Follow-up (12 weeks)
|
Motor Activity Log - 14, Amount of Use sub scale
Tidsramme: Follow-up (12 weeks)
|
Self-reported amount of upper limb use in daily life
|
Follow-up (12 weeks)
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Global Rating of Perceived Change
Tidsramme: Post-intervention (6 weeks)
|
Post-intervention (6 weeks)
|
|
Global Rating of Perceived Change
Tidsramme: Follow-up (12 weeks)
|
Follow-up (12 weeks)
|
|
Concomitant movement therapy
Tidsramme: Post-intervention (6 weeks)
|
Time spend at Movement therapy (e.g., Physiotherapy, Occupational therapy)
|
Post-intervention (6 weeks)
|
Concomitant movement therapy
Tidsramme: Follow-up (12 weeks)
|
Follow-up (12 weeks)
|
|
Adverse Events
Tidsramme: Baseline (0 week)
|
Safety
|
Baseline (0 week)
|
Adverse Events
Tidsramme: Post-intervention (6 weeks)
|
Safety
|
Post-intervention (6 weeks)
|
Adverse Events
Tidsramme: Follow-up (12 weeks)
|
Safety
|
Follow-up (12 weeks)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Andreas R Luft, Prof. MD, University of Zurich
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2017-00948
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Wrist-worn wearables
-
Leo WangBTS InternationalFullførtHypertensjon | Effektivitet av håndledds BPM-målingKina
-
OrthopusHandicap InternationalRekrutteringSår og skader | Amputasjon; Traumatisk, arm, øvre | Amputasjon; Traumatisk, hånd, på håndleddsnivå | Amputasjon; Traumatisk, Arm: UnderarmNepal
-
Melissa Voigt HansenFullførtBrystkreft | Angst | DøgnrytmeforstyrrelserDanmark